Last reviewed · How we verify
Topical Ascorbic Acid
At a glance
| Generic name | Topical Ascorbic Acid |
|---|---|
| Sponsor | Center for Biomedical Research, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30 (PHASE4)
- Natural Bioactive Gel for Peri-Implantitis (NA)
- Efficacy of Microneedling With Vitamin C in Performing Gingival Depigmentation (PHASE1, PHASE2)
- Topical Dexamethasone, Ascorbic Acid, and BGP for Enhancing Implant Osseointegration (NA)
- Derma Pen as Treatment of Gingivitis Induced by Orthodontics (NA)
- ANTIPIGMENTING OR DEPIMENTING EFFICACY UNDER PART OF VISIBLE LIGHT
- Impact of a Topical Cosmetic Product on Women's Hair (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical Ascorbic Acid CI brief — competitive landscape report
- Topical Ascorbic Acid updates RSS · CI watch RSS
- Center for Biomedical Research, Inc. portfolio CI